Braxia Scientific Launches Multiple-Dose Psilocybin Clinical Trial for Treatment-Resistant Depression
Braxia Scientific Corp. (CSE: BRAX), formerly Champignon Brands, announced today that its clinical research and development team will start a randomized
Read more